University of Wisconsin Hospitals and Clinics
Madison, Wisconsin, 53792, United States
NCT Number: NCT01573195
The purpose of this study is to pilot the use of best practices alerts to enhance an antimicrobial stewardship program using the electronic medical record, EPIC.
Looking for future studies?
Notify MeAll sexes
Observational
Madison, Wisconsin, 53792, United States
The purpose of this study is to pilot the use of best practices to enhance an antimicrobial stewardship program using the electronic medical record, EPIC. Screening information technology tools via SETNET/Safety SUrveyor(Premier) and the electronic anti-infective order form would allow for sufficient medical record review to create best practices alerts for the purpose of appropriate de-escalation of anti-invectives.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: One Year
after issuing the BPA for deescalation, the responding healthcare provider will respond in one of the manners above
Time frame: One year
The antiinfective use before and after the BPA will be analyzed in detail. The number of antibiotics, percentage decrease(or less likely increase) in antiinfectives in the 3 days before BPA , and 11 days after the BPA will be analyzed. A cost analysis will be performed. Patient outcomes will not be assessed.
University of Wisconsin, Madison
Other
Implementation of Antimicrobial Stewardship and Decision Support Into the EPIC Electronic Medical Record
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07172932
Antibiotic Resistant Infection, Bacterial Infections
Çankaya, Ankara, Turkey (Türkiye)
View Trial DetailsNCT03452839
Antibiotic Resistant Infection, Critical Illness
Dubrava, Croatia
View Trial DetailsNCT03865706
Antibiotic Resistant Infection, Critical Illness
New York, United States
View Trial DetailsNCT05950984
Adult Children, Antibiotic Resistant Infection
London, United Kingdom
View Trial Details